Genes in MS Patients Farmingdale NY

Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports. "Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release.

Local Companies

Charles Hwu
(718) 670-3103
182-19 Horace Harding Expy
Fresh Meadows, NY
Tudor Gavrilesco
(516) 572-6431
2201 Hempstead Tpke
East Meadow, NY
Stephen Gulotta
(516) 365-5599
100 Port Washington Blvd
Roslyn, NY
Mark Robert Kahn
(516) 826-7800
2592 Merrick Rd # B
Bellmore, NY
Lawrence Werner
(631) 265-1684
222 E Main St # 103
Smithtown, NY
Leslie Taft Aiuto
(516) 622-5050
865 Northern Blvd. Suite 101
Great Neck, NY
Saeid Khodabaksh
(718) 712-2200
235-20 147th Avenue
Rosedale, NY
Edward Oruci
(516) 365-2900
100 Port Washington Blvd
Roslyn, NY
Araceli Dantes
(631) 661-0545
420 W Main St
Babylon, NY
Ida G D Giordano
(631) 673-6909
17 Prospect St
Huntington, NY
Data Provided by:
  

Provided By:

FRIDAY, Sept. 11 (HealthDay News) -- Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports.

"Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release. "This study asked, among those who have MS, why do some do well with the disease while others do poorly, and what might be the genetic determinants of this difference in outcome."

The study, which was scheduled to be presented Friday at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, identified two genes that appear to lead to repair of damage caused by multiple sclerosis in mice.

Multiple sclerosis affects about 330,000 people in the United States. The disease targets the central nervous system and damages the insulation that covers nerves. People with the disease suffer from a variety of symptoms, including loss of strength, vision, balance and muscle coordination.

"It's possible that the identification of these genes may provide the first important clue as to why some patients with MS do well, while others do not," Bieber said in the news release.

More information

Learn more about the disease from the National Multiple Sclerosis Society.

SOURCE: Mayo clinic, news release, Sept. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Genetic Clues for Skin Cancer Therapies Farmingdale NY
Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.
- Gene Therapy for Parkinson's Farmingdale NY
- Exercise for Chemotherapy Patients Farmingdale NY
- Depression in Heart Disease Patients Farmingdale NY
- Gene Variants and Alzheimer's Risk Farmingdale NY
- Side Effect Of Chemotherapy Drugs Farmingdale NY
- Doctor-Patient Talk for Hypertension Farmingdale NY
- Hospice: Getting Back Control of Your Life Farmingdale NY
- Differences Between Hospice and Palliative Care Farmingdale NY
- High Blood Pressure Genes Farmingdale NY